K. Suh

发表

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes

A. Sood, Wei Hu, A. Goy, 2014, Journal of Ovarian Research.

Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries

Rajendra Gharbaran, K. Suh, I. Preeshagul, 2013, Journal of Cardiothoracic Surgery.

Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine

Kip Nalley, Fathi Elloumi, F. Elloumi, 2013, Journal of oncology.

Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine

A. Goy, M. R. Akl, A. Pecora, 2016, Oncotarget.

Nanomedicine in Cancer

Takemi Tanaka, K. Suh, 2011 .

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

A. Inamdar, K. Suh, N. Ayoub, 2020, Oncotarget.

Bortezomib in mantle cell lymphoma.

A. Goy, K. Suh, K. S. Suh, 2008, Future oncology.

Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.

A. Goy, Takemi Tanaka, A. Pecora, 2018, Breast.

Combination of High Dose Rate Radiations (10X FFF/2400 MU/min/10 MV X-rays) and Paclitaxel Selectively Eliminates Melanoma Cells

Sreeja Sarojini, K. Suh, M. Keck, 2021, bioRxiv.

Proactive Biobanking to Improve Research and Health Care

A. Goy, Sreeja Sarojini, A. Pecora, 2012 .

p21WAF1/CIP1 Is a Common Transcriptional Target of Retinoid Receptors

L. D. De Luca, Takemi Tanaka, K. Suh, 2007, Journal of Biological Chemistry.

Protein calorie malnutrition, nutritional intervention and personalized cancer care

A. Goy, A. Pecora, K. Suh, 2017, Oncotarget.

Prediction of clinical outcomes using the pyrolysis, gas chromatography, and differential mobility spectrometry (Py-GC-DMS) system

A. Snyder, S. Nair, A. Inamdar, 2016 .

Prediction of clinical outcomes in mantle cell lymphoma using the ACB 2000 pyrolysis 1 system

Waleed, Maswadeh, S. Nair, 2015 .

Nanomedicine in Cancer

Takemi Tanaka, K. Suh, K. S. Suh, 2011 .

Synergetic effect of high dose rate radiations (10× FFF/2400 MU/min/10 MV x‐rays) and paclitaxel selectively eliminates melanoma cells

Sreeja Sarojini, K. Suh, M. Keck, 2022, Cancer reports.

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine

A. Goy, M. R. Akl, K. Suh, 2015, Oncotarget.

A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes

A. Goy, Sreeja Sarojini, A. Pecora, 2015, Melanoma research.

Circulating tumor cells in Hodgkin's lymphoma - a review of the spread of HL tumor cells or their putative precursors by lymphatic and hematogenous means, and their prognostic significance.

A. Goy, Rajendra Gharbaran, K. Suh, 2014, Critical reviews in oncology/hematology.

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma

W. C. Chan, R. Gascoyne, B. Sander, 2014, Oncogene.

Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice.

H. Rui, D. Volk, D. Gorenstein, 2015, Toxicology and applied pharmacology.

The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer

A. Goy, A. Tamir, Takemi Tanaka, 2016, Journal of Ovarian Research.

Ovarian cancer biomarkers for molecular biosensors and translational medicine

A. Goy, Hiren K. Patel, Patrick Blake, 2010, Expert review of molecular diagnostics.

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

A. Goy, M. R. Akl, K. Suh, 2016, Oncotarget.

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

Amit Verma, Adrian Wiestner, Samir Parekh, 2010, Blood.

High-Resolution Sequencing Identifies NOXA1 De-Methylation As a Novel Strategy to Overcome Bortezomib Resistance in Mantle Cell Lymphoma

W. Wilson, A. Verma, A. Wiestner, 2011 .

Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting

M. Ferrari, D. Volk, D. Gorenstein, 2010, Oncotarget.

The role of the ubiquitin proteasome system in lymphoma.

A. Goy, Sreeja Sarojini, Takemi Tanaka, 2013, Critical reviews in oncology/hematology.

Early Detection Biomarkers for Ovarian Cancer

A. Goy, A. Tamir, Sreeja Sarojini, 2012, Journal of oncology.

Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine

Patrick Blake, Christian Castaneda, Kip Nalley, 2015, Journal of Clinical Bioinformatics.

Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis.

H. Rui, D. Volk, D. Gorenstein, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

The effect of soluble E-selectin on tumor progression and metastasis

H. Rui, D. Gorenstein, M. Kamal, 2016, BMC Cancer.

Cancer Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures

A. Goy, K. Suh, Y. Remache, 2011, Journal of tissue engineering.

Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients

A. Goy, Sreeja Sarojini, Takemi Tanaka, 2013, Journal of Hematology & Oncology.